BioSyent Inc. BIOYF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 95.15% | 32.54% | 10.40% | 26.65% | 12.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 95.15% | 32.54% | 10.40% | 26.65% | 12.55% |
| Cost of Revenue | 160.32% | 48.11% | 36.12% | 41.39% | 19.65% |
| Gross Profit | 76.48% | 27.60% | 4.50% | 22.58% | 10.67% |
| SG&A Expenses | 73.49% | 28.14% | 11.08% | 21.59% | -2.24% |
| Depreciation & Amortization | 393.17% | 142.28% | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 107.18% | 36.28% | 17.54% | 27.59% | 7.28% |
| Operating Income | 59.47% | 22.33% | -8.26% | 24.30% | 31.78% |
| Income Before Tax | 44.53% | 8.89% | 10.56% | 21.47% | 26.30% |
| Income Tax Expenses | 53.96% | 17.64% | -23.40% | 43.54% | 26.30% |
| Earnings from Continuing Operations | 41.13% | 5.74% | 23.98% | 15.09% | 26.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 41.13% | 5.74% | 23.98% | 15.09% | 26.31% |
| EBIT | 59.47% | 22.33% | -8.26% | 24.30% | 31.78% |
| EBITDA | 81.60% | 28.47% | -3.03% | 26.88% | 34.21% |
| EPS Basic | 39.43% | 5.16% | 26.65% | 18.42% | 30.12% |
| Normalized Basic EPS | 48.73% | 17.21% | -5.19% | 24.98% | 30.11% |
| EPS Diluted | 39.15% | 5.14% | 25.99% | 18.32% | 29.93% |
| Normalized Diluted EPS | 48.75% | 17.09% | -5.58% | 24.89% | 29.53% |
| Average Basic Shares Outstanding | 1.23% | 0.59% | -2.04% | -2.82% | -2.93% |
| Average Diluted Shares Outstanding | 1.13% | 0.71% | -1.75% | -2.67% | -2.51% |
| Dividend Per Share | 9.97% | 15.23% | 11.84% | 10.00% | 9.73% |
| Payout Ratio | -0.21% | 0.09% | -0.11% | -0.07% | -0.15% |